There were 2,447 press releases posted in the last 24 hours and 441,337 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image